Skip to main content
. 2016 May 23;7(26):40189–40199. doi: 10.18632/oncotarget.9561

Figure 3. Fibronectin (FN) levels in plasma in the test set using two types of enzyme-linked immunosorbent assays (ELISA) in test set.

Figure 3

A. FN levels on circulating extracellular vesicles in plasma using Method 1. B. FN levels in plasma using Method 2. C. CD63 levels in plasma. All data were obtained using samples from the same subjects. Healthy controls (HC), n = 30; non-cancerous diseases (Non-C), n = 30; benign breast tumors (bB), n = 20; breast cancer (BC), n = 150; early-stage breast cancer (early-BC), n = 119; after surgery (AS), n = 40. The black horizontal lines are means, and error bars are standard errors.